(R)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine synthesis
- Product Name:(R)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine
- CAS Number:109838-85-9
- Molecular formula:C9H16N2O2
- Molecular Weight:184.24
420-37-1
235 suppliers
$17.00/5g
143673-66-9
121 suppliers
$9.00/250mg
109838-85-9
182 suppliers
$40.00/500 mg
Yield:109838-85-9 71.5%
Reaction Conditions:
Stage #1:trimethoxonium tetrafluoroborate;(R)-3-(1-methylethyl)-piperazine-2,5-one in dichloromethane at 20; for 41 h;
Stage #2: with ammonia;water in dichloromethane at 0; for 1 h;
Steps:
1.A; 2.A (S)-Methyl 2-(5-(2,4-difluorophenoxy)-1-isobutyl-1H-indazole-6-carboxamido)-4-(dimethylamino)-2-methylbutanoate (9a)
Step A: Preparation of (R)-2-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine (1): To a 2 L round-bottomed flask were added (R)-3-isopropylpiperazine-2,5-dione (20.7 g, 133 mmol), Me3OBF4 (49.0 g, 331 mmol) and CH2Cl2 (500 mL). The slurry was stirred vigorously at room temperature under nitrogen atmosphere. After stirring 18 hours, the slurry became a clear solution with very viscous yellow oil settling on the bottom of the flask. An additional equivalent of Me3OBF4 (19.6 g, 133 mmol) was added and the mixture was stirred at room temperature. After 23 hours, the mixture was cooled in an ice bath, and 200 g of ice and 100 mL of concentrated ammonium hydroxide solution (28%) were added to the reaction mixture. The reaction mixture was stirred in an ice bath for 1 hour. The layers were separated and aqueous layer was extracted with CH2Cl2 (2*50 mL). The combined organic layers were washed with saturated NaHCO3 solution (2*100 mL) and brine (100 mL), dried over K2CO3, filtered through a Celite pad, and concentrated under reduced pressure to provide 25.9 g of light brown oil. The crude material was purified by chromatography with 1:4 ether/pentane to provide 17.464 g of compound 1 as a colorless oil (71.5% yield). 1H NMR (400 MHz, CDCl3) δ 4.08-3.94 (m, 3H), 2.95 (s, 3H), 2.87 (s, 3H), 2.30-2.18 (m, 1H), 1.04 (d, J=7.03 Hz, 3H), 0.76 (d, J=6.64 Hz, 3H).
References:
ARRAY BIOPHARMA INC. US2006/264431, 2006, A1 Location in patent:Page/Page column 20-21
1685-33-2
261 suppliers
$8.00/1g
109838-85-9
182 suppliers
$40.00/500 mg
32402-31-6
0 suppliers
inquiry
109838-85-9
182 suppliers
$40.00/500 mg
640-68-6
445 suppliers
$8.00/10g
109838-85-9
182 suppliers
$40.00/500 mg
22838-58-0
297 suppliers
$5.00/1g
109838-85-9
182 suppliers
$40.00/500 mg